ArticleFrontiers in oncology2026

Pretreatment TyG-BMI predicts CD19 CAR-T persistence and prognosis in diffuse large B-cell lymphoma.

Zelin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.